GDF11 and obesity disorder: Even though the systemic effects and underlying mechanisms of GDF11 action in obesity and associated metabolic disorders remain poorly understood, further research efforts are essential for the development of safe GDF11-based therapeutic treatments for obesity and related comorbidities (CMDs), including AD.